“I am excited to help build amazing companies that develop world-class teams to deliver breakthrough medicines to patients.”
Jigar Raythatha is passionate about building great teams that can advance life-changing medicines. Prior to joining Third Rock Ventures, he served as president and chief executive officer of Constellation Pharmaceuticals, Inc. from 2017 until its acquisition in 2021. Jigar also led the corporate development function at Constellation from 2009 to 2013. Jigar re-joined Constellation from Jounce Therapeutics Inc., where he held the role of chief business officer from the inception of the company through its IPO. Previously, Jigar worked with Red Abbey Venture Partners, initially, as a Kauffman Fellow and later as a principal and venture partner. Earlier in his career, Jigar held roles of increasing responsibility at Biogen and A.T. Kearney. He earned an MBA from Columbia University and a B.A. in biochemistry and economics from Rutgers University. Jigar is currently a member of the board of directors at Jounce Therapeutics (JNCE) and the American Cancer Society New England Area.
Outside of work, Jigar loves to spend time with his wife and two daughters and is an avid fan of baseball.